Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/20/23 16:13 | 1/19/23 | CRBU | Health | BioPrd | Biological Products, (No Diag | Rizvi Syed Ali-Aamir | CA | O | Chief Me | S | -36 | 6.31 | 0 | -6 | -9 | 59 | D | ||||||||||||||
10/7/22 17:13 | 10/6/22 | CRBU | Health | BioPrd | Biological Products, (No Diag | Fischesser Ryan | CA | O | VP of Fi | S.d | -108 | 10.80 | 0 | -10 | -8 | 116 | D | ||||||||||||||
8/26/22 17:42 | 8/25/22 | CRBU | Health | BioPrd | Biological Products, (No Diag | Kanner Steven | CA | O | Chief Sc | S.d | -485 | 11.22 | 0 | -43 | -13 | 302 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |